Severity of depressive symptoms among at-risk individuals during COVID-19

October 26, 2020

What The Study Did: The levels of severity of depressive symptoms among at-risk individuals during the COVID-19 pandemic in the UK were examined in this study.

Authors: Eleonora Iob, M.Sc., of University College London, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.26064)

Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
-end-
Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.26064?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=102620

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

JAMA Network Open

Related Depressive Symptoms Articles from Brightsurf:

Severity of depressive symptoms among at-risk individuals during COVID-19
The levels of severity of depressive symptoms among at-risk individuals during the COVID-19 pandemic in the UK were examined in this study.

Frequent social media use influences depressive symptoms over time among LGBTQ youth
Frequent social media use can impact depressive symptoms over time for LGBTQ youth, according to research from a Washington State University communication professor.

The Lancet Psychiatry: Single dose of psychoactive component in cannabis could induce psychotic, depressive, and anxiety symptoms in healthy people
A single dose of the main psychoactive component in cannabis, tetrahydrocannabinol (THC), can induce a range of psychiatric symptoms, according to results of a systematic review and meta-analysis of 15 studies including 331 people with no history of psychotic or other major psychiatric disorders, published in The Lancet Psychiatry journal.

Study links depressive symptoms during pregnancy with lowered immunity in infants
A woman's mental health during pregnancy has a direct influence on the development of her child's immune system, according to a new study from pediatric researchers at the University of Alberta.

Digital intervention reduces depressive symptoms in people living with HIV
New study by Dr. Alicia Hong, Professor at George Mason University's College of Health and Human Services and her colleagues in China tests WeChat social media app intervention with 300 people living with HIV.

Researchers identify link between decreased depressive symptoms, yoga and the neurotransmitter GABA
The benefits of yoga have been widely documented by scientific research, but previously it was not clear as to how yoga exerts its physiologic effect.

Black teens face racial discrimination multiple times daily, suffer depressive symptoms
Black teenagers experience daily racial discrimination, most frequently online, which can lead to negative mental health effects, according to a Rutgers researcher.

Anti-inflammatory agents can effectively and safely curb major depressive symptoms
Anti-inflammatory agents, such as aspirin/paracetamol, statins, and antibiotics, can safely and effectively curb the symptoms of major depression, finds a pooled analysis of the available evidence, published online in the Journal of Neurology Neurosurgery & Psychiatry.

Teens taking oral contraceptives may be at increased risk for depressive symptoms
In a study published in JAMA Psychiatry, investigators report that there was no association between oral contraceptive use and depressive symptom severity in the entire population they studied (ages 16 through 25).

How were oral contraceptives, concurrent depressive symptoms associated among adolescents, young women?
This observational study examined associations between depressive symptoms and oral contraceptive use in adolescents and young women and how those associations might differ by age.

Read More: Depressive Symptoms News and Depressive Symptoms Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.